This is consistent with low‐level microglial activity occurring in ALS gene carriers in the years before symptom onset, though additional longitudinal analysis of healthy control subjects is required to confirm that the trajectory of rising CHIT1 differs between at‐risk participants and healthy controls. Here, CHIT1 is linked to amyotrophic lateral sclerosis.